Paget Minerals Corp (PGTMF) 0.0363 $PGTMF Paget Minerals

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Paget Minerals Corp (PGTMF) 0.0363 $PGTMF

Paget Minerals Shareholders Approve Share Consolidation
Marketwired - Tue Jan 19, 12:18PM CST
Paget Minerals Corp. ("Paget" (TSX VENTURE: PGS) announces that the shareholders have approved the 15 to 1 share consolidation as previously announced, at the Special Meeting today. The funds raised in the subscription receipts financing will be released to Paget shortly.
PGS.VN: 0.070 (+0.010)

Paget Minerals Completes Financing
Marketwired - Mon Jan 04, 12:45PM CST
Paget Minerals Corp. ("Paget" (TSX VENTURE: PGS) is pleased to announce that the $100,000 financing announced on November 16, 2015 has been increased to $150,000 and is fully subscribed. The financing includes $47,500 from Pacific Opportunity Capital Ltd. ("POC", a private company in which Mark T. Brown, CPA, CA, a director of the Company, is the President.
PGS.VN: 0.070 (+0.010)

Paget Minerals Announces Share Consolidation and Financing
Marketwired - Mon Nov 16, 8:03AM CST
Paget Minerals Corp. ("Paget" (TSX VENTURE: PGS) announces that it will hold a special meeting (the "Meeting" of its shareholders on Tuesday January 19, 2016 to seek shareholder approval of a proposed consolidation (the "Consolidation" of the Company's fully paid and issued common shares on a ratio of one (1) post-Consolidation common share for every fifteen (15) pre-Consolidation common shares. The Company currently has 91,197,475 issued and outstanding common shares and there is expected to be 6,079,832 issued and outstanding common shares upon completion of the Consolidation.
PGS.VN: 0.070 (+0.010)

Paget Obtains Shareholder Approval for Vending of the Ball Creek Project, BC
Marketwired - Tue Jun 16, 1:01PM CDT
Paget Minerals Corp. (TSX VENTURE: PGS), ("Paget" or the "Company" is pleased to announce that further to the Company's news release on April 27, 2015, the Ball Creek agreement (the "Agreement" between Paget and Evrim Resources Corp. (TSX VENTURE: EVM) ("Evrim" has been approved by Paget's shareholders. The Agreement remains subject to acceptance by the TSX Venture Exchange.
EVM.VN: 0.310 (+0.005), PGS.VN: 0.070 (+0.010)

Evrim Formally Acquires the Ball Creek Project in British Columbia
ACCESSWIRE - Tue Jun 16, 7:35AM CDT
VANCOUVER, BC / ACCESSWIRE / June 16, 2015 / Evrim Resources Corp. (TSXV: EVM) ("Evrim" or the "Company" is pleased to announce that further to the Company's news release on April 27, 2015, the Ball Creek agreement (the "Agreement" between Evrim and Paget Minerals Corp. ("Paget" has been approved by Paget's shareholders. Ball Creek is an early stage exploration target prospective for copper-gold-molybdenum porphyry and epithermal gold-silver deposits. The project covers a 520 square kilometre area in the Golden Triangle in northwest British Columbia.
EVM.VN: 0.310 (+0.005)

Paget Vends Ball Creek Project in British Columbia
Marketwired - Mon Apr 27, 7:52AM CDT
Paget Minerals Corp. (TSX VENTURE: PGS), ("Paget" or the "Company" is pleased to announce that Evrim Resources Corp. (TSX VENTURE: EVM) ("Evrim" has signed an agreement with Paget to acquire a 100% interest in the Ball Creek Project in northwest British Columbia. Drilling and surface work on the 52,000 hectare property has shown significant copper-gold-molybdenum porphyry-style mineralization and indications of epithermal gold-silver deposits.
EVM.VN: 0.310 (+0.005), PGS.VN: 0.070 (+0.010)

Evrim Acquires the Ball Creek Project in British Columbia
ACCESSWIRE - Mon Apr 27, 7:34AM CDT
VANCOUVER, BC / ACCESSWIRE / April 27, 2015 / Evrim Resources Corp. (TSX VENTURE: EVM) ("Evrim" or the "Company" is pleased to announce that it has signed an agreement with Paget Minerals Corp. ("Paget" to acquire a 100% interest in the Ball Creek project in northwest British Columbia. Ball Creek is an early stage exploration target covering 52,442 hectares of ground prospective for copper-gold-molybdenum porphyry and epithermal gold-silver deposits.
EVM.VN: 0.310 (+0.005)

Paget Minerals-Resignation of Director
Marketwired - Thu Mar 19, 11:14AM CDT
Paget Minerals Corp. (TSX VENTURE: PGS), ("Paget" or the "Company" announces the resignation of Kevin Nishi as a director of the company for personal reasons.
PGS.VN: 0.070 (+0.010)

Paget Announces Completion of Shares for Debt Transaction
Marketwired - Mon Mar 02, 5:17PM CST
Paget Minerals Corp. ("Paget" or the "Company" (TSX VENTURE: PGS) wishes to announce that it has completed the shares for debt transaction announced on January 19, 2015 after receiving the approval of the TSX Venture Exchange to settle indebtedness with a creditor of the Company.
PGS.VN: 0.070 (+0.010)

Paget Announces Shares for Debt Transaction
Marketwire Canada - Mon Jan 19, 5:42PM CST
Paget Minerals Corp. ("Paget" or the "Company" (TSX VENTUREGS) wishes to announce that it has entered into a debt settlement agreement with a creditor of the Company pursuant to which the Company has agreed to issue an aggregate of 882,968 common shares ("Shares" at a deemed price of $0.05 per Share in order to settle certain obligations of the Company under an option agreement dated August 17, 2012, as amended on April 25, 2013. The Company decided to satisfy this outstanding indebtedness with Shares in order to preserve its cash for operations.
PGS.VN: 0.070 (+0.010)

Paget Minerals Grant of Stock Options
Marketwired - Thu Dec 11, 1:06PM CST
Paget Minerals Corp. (TSX VENTURE: PGS) ("Paget" or the "Company" announces that it has granted a total of 1,750,000 incentive stock options (the "Options" to directors and officers of the Company. The Options are exercisable at $0.05 per share for a period of five years from the date of grant and shall vest as to 100% upon the date of grant. The Options were granted pursuant to the Company's shareholder-approved stock option plan and are subject to the policies of the TSX Venture Exchange and any applicable regulatory hold periods.
PGS.VN: 0.070 (+0.010)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading